Responses
Regular and Young Investigator Award Abstracts
Clinical Trial Completed
581 Final analysis of 2-THE-TOP: a phase 2 study of TTFields (Optune) plus pembrolizumab plus maintenance temozolomide (TMZ) in patients with newly diagnosed glioblastoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
